CompletedNot Applicable

Home Rehabilitation After Hip Fracture

Spain80 participantsStarted 2024-02-01

Plain-language summary

This study will examine whether a home-based rehabilitation program can help older adults recover after surgery for a hip fracture. The program is delivered by a specialized "Hospital-at-Home" unit, which provides hospital-level care in the patient's home. Participants in this study are adults aged 65 years and older who have undergone hip fracture surgery at Hospital Universitari i Politècnic La Fe in Valencia, Spain. Instead of remaining in the hospital after surgery, participants will be admitted to the Hospital-at-Home program. A multidisciplinary medical team will provide comprehensive care at home, including medication management, wound care, and in-home physical therapy. The primary goal of the study is to assess recovery of walking ability and mobility within the home. The study will also evaluate overall functional improvement, frailty, and survival. Participants will be assessed at the start of the program and again at 45 days and 180 days after surgery. The information collected will help determine whether this type of home-based care is an effective option for supporting recovery and independence in older adults after a hip fracture. Recruitment for the study began in February 2024 and is expected to continue for one year.

Who can participate

Age range

65 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * \- Patients aged 65 years or older undergoing surgery for traumatic hip fracture. * Ability to actively collaborate in the physiotherapy program. * Compliance with the UHD admission criteria (contact telephone number, identified caregiver, and residence within the geographical area of the Hospital Universitari i Politècnic La Fe). Exclusion Criteria: * \- Patients residing outside the geographical area covered by the La Fe hospital UHD. * Refusal to participate in the follow-up. * Clinical instability or end-of-life situation (oncologic or non-oncologic). * Cognitive impairment that prevents collaboration. * Institutionalized patients.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Walking ability and home transfers

Timeframe: assessed at different time points (prior, admission to the UHD, and at 45 and 180 days).

Trial details

NCT IDNCT07478445

SponsorInstituto de Investigacion Sanitaria La Fe

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-02-26

View on ClinicalTrials.gov More Hip Fractures (ICD-10 72.01-72.2) trials